Stocks Heading Up Early: WINN, TWER, GTIV, INHX, AVNR, ZLCS

The markets are up this morning despite political instability in the Korean Peninsula following Kim-Jong il’s death. Home builder sentiment rose for the third straight month as well giving the markets a little boost. Taking a look at the markets around 10:45 am EST the Dow is up 45 points, the Nasdaq is up 13 points and the S&P is up 3 points. Volume will probably be relatively light this week baring any breaking news out of Europe as traders get ready for the holidays. Here’s a quick look at stocks heading up this morning.

Winn-Dixie Stores Inc. (NASDAQ:WINN) is up 70.63% this morning at $9.26. WINN has traded 39.8 million shares so far today, well above its daily average volume of just 951 thousand shares. Winn-Dixie shares jumped this morning after Bi-Lo said it would acquire the company for $9.50 a share. The company has a current market cap of 520.65 million.

Towerstream Corporation (NASDAQ:TWER) is up 15.18% in early trading at $2.20. TWER has traded 493 thousand shares so far today, already above its daily average of 486 thousand shares. The company has a market cap of 120.67 million.

Gentiva Health Services Inc. (NASDAQ:GTIV) is up 9.06% this morning at $6.62. GTIV has traded 389 thousand shares so far today and averages 974 thousand shares a day on average. Gentiva Health Services has a market cap of 206.32 million.

Inhibitex, Inc. (NASDAQ:INHX) is up 5.55% this morning at $11.02. INHX has traded 2.3 million shares so far today and trades 2.6 million shares a day on average. INHX stock is bouncing today after a big sell off on Friday due in large part to news on another company, Pharmasset. The company has a market cap of 878.45 million.

Avanir Pharmaceuticals (NASDAQ:AVNR) is up 7.30% today at $1.91. AVNR has traded 1 million shares so far today and trades 1.6 million shares a day on average. AVNR has been trending lower most of the month and is down from a December high of around $2.60. Avanir has a market cap of 243.76 million.

Zalicus Inc. (NASDAQ:ZLCS) is up 5.17% today at $1.22. ZLCS has traded 649 thousand shares so far today and trades 987 thousand shares a day on average. Zalicus announced this morning they have initiated Phase 1 clinical trial of Z944. The company has a market cap of 122.35 million.

written by

An avid market watcher, Martin enjoys the tech arena the most with the Nasdaq being his main area of focus. A finance major, Martin is working to the goal of one day ringing the bell at the NYSE.
Related Posts

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

© Copyright - Active Investor
Real Time Analytics